Loading clinical trials...
Loading clinical trials...
A Phase 2 Open-Label, Single-Arm Trial of the Efficacy of Topical Remetinostat on Basal Cell Carcinoma in Patients
Conditions
Interventions
Remetinostat
Locations
1
United States
Stanford University, School of Medicine
Palo Alto, California, United States
Start Date
July 7, 2018
Primary Completion Date
July 7, 2020
Completion Date
December 31, 2020
Last Updated
June 8, 2021
NCT07144384
NCT02579551
NCT02699723
NCT01033019
Lead Sponsor
Kavita Sarin
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions